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ABSTRACT
Purpose To evaluate the potential of poly(amido amine)-
basedmultilayered thin films in surface mediated drug release.
Methods Multilayered thin films were prepared from copol-
ymers of phenylboronic acid-functional poly(amido amine)s
and chondroitin sulfate (ChS) in the presence of Alizarin
Red S (ARS) as a reporter molecule. Multilayer buildup and
ARS incorporation were evaluated with UV–vis spectroscopy.
Glucose responsiveness of the multilayers was investigated.
Finally, cellular uptake of ARS by COS-7 cells grown on the
films was assessed.
Results Multilayers based on alcohol containing polymers
(ABOL-BA-PAA#ChS+ARS) displayed higher ARS incor-
poration than multilayers based on amine-containing poly-
mers (DAB-BA-PAA#ChS+ARS). At physiological pH, a
swift initial release of up to ~40% of the ARS content was
observed during the first 12 h of incubation, followed by a
much slower, gradual release of ARS. The multilayers were
further evaluated by culturing COS-7 cells on top of
multilayer-coated well plates. Cellular uptake of the fluores-
cent ARS-boronate ester was quantified through flow cytom-
etry, and a maximum uptake of up to 30% was observed.
Confocal microscopy confirmed the presence of ARS-
boronate ester-containing particles in the nuclei of cells.
Conclusions The investigated multilayered thin films are ef-
fective in surface-mediated delivery of the model compound
ARS. These multilayered surfaces are promising as drug-
releasing delivery surface for coating stents, prostheses, and
other implants.
KEY WORDS biodegradable polymers . chondroitin
sulfate . dynamic covalent chemistry . layer-by-layer assembly .
poly(vinyl alcohol)
ABBREVIATIONS
ABOL 4-aminobutanol
ABOL-BA-PAA p(CBA-ABOL50%/4AMPBA50%)
ARS Alizarin red S
BA Boronic acid
BA-PAA Phenylboronic acid-functional
poly(amido amine)s
CBS Citrate buffered saline
ChS Chondroitin sulfate
DAB-BA-PAA p(CBA-DAB50%/4AMPBA50%)
DMEM Dulbecco’s Modified Eagle’s
medium
FACS Fluorescence-activated cell sorting
LbL Layer-by-layer
LFH Laminar flow hood
PDL-TCPS Poly-D-lysine coated tissue culture
polystyrene
PS Polystyrene
PVA Poly(vinyl alcohol)
INTRODUCTION
The coverage of the surface of materials for biomedical appli-
cations with multilayered thin films offers the possibility of
providing to these materials a delivery system that is
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controllable in both the amount of loading, as well as the
release of bioactive compounds (1,2). The amount of incorpo-
rated drug can be tuned by the number of layers in the film,
which may reduce side effects and wasting of expensive drugs.
Release profile and responsiveness can be altered by careful
choice of appropriate macromolecules as main multilayer
components (3). Moreover, highly localized delivery of incor-
porated drugs can be achieved, which may be beneficial for
applications such as providing anti-inflammatory or anti-
thrombotic properties to the surface of an implant.
Unlike hydrogel systems, where small molecules can be
easily incorporated by simply dissolving the compound of in-
terest in the hydrogel-forming solutions, incorporating small
molecules via the layer-by-layer (LbL) alternate dipping tech-
nique requires that the molecule has strong enough associa-
tion to at least one of the macromolecules forming the layers
to shift the equilibrium away from the entropically more stable
dissociated state and to prevent rapid diffusive release from
the films. This requirement cannot be easily met, and is par-
ticularly difficult to achieve by electrostatic interactions alone.
Therefore, several techniques are commonly utilized, as
reviewed by Pavlukhina and Sukhishvili (4), such as using drug
crystals as the substrate for multilayer build-up (5,6), interlayer
crosslinking (7), pre-encapsulation of the drug molecules into
micelles or particles (8), linking the drug molecules to one of
the macromolecules either covalently (i.e. in a pro-drug ap-
proach) (9) or through the use of host-guest interactions (10),
and other more specific complexation/interaction mecha-
nisms (11).
An interesting alternative possibility for biologically active
molecules possessing a vicinal diol functionality is the utiliza-
tion of reversible binding of this diol group to boronic acids.
The functional boronic acid (BA) moiety has received a lot of
attention in the biomedical field, especially in the develop-
ment of sensor, due to its ability to selectively form dynamic
coordinative covalent esters with various diol-containing spe-
cies such as glucose (12). In responsive drug delivery applica-
tions, the dynamic nature of boronate ester formation has
been used to provide glucose responsiveness for treatment of
diabetes, obesity, cancer andHIV (13), and to provide binding
to the saccharides at the surface of mammalian cells (14,15).
More interestingly, in hydrogel systems this dynamic covalent
interaction provides the hydrogels with the ability to self-heal
and adopt the specific shape of containers or cavities, a
desirable property for wound-dressing and topical appli-
cations (16,17).
Parallel to the increasing interest in boronate ester forma-
tion, ARS has emerged as one of the most commonly used
reporter molecules to analytically determine the binding con-
stants of BA moieties to diols under relevant conditions
(18,19). This practice is attributed to the particular fluores-
cence properties of ARS upon ester formation with a BA
moiety under physiologically relevant conditions. Structurally,
the anthraquinone derivative ARS contains a catechol moiety
responsible for the strong binding with BA. ARS can therefore
be seen as a model for catechol-containing drugs such as do-
pamine, epinephrine/adrenaline, and many others with main
pharmacological applications in the nervous system (treat-
ment of Parkinson’s, schizophrenia, attention deficit hyperac-
tivity disorder (ADHD)), lung diseases (chronic obstructive
pulmonary disease (COPD), asthma), and heart diseases (car-
diac arrest, anaphylaxis, hypertension) (20). The characteristic
fluorescence properties of the ARS-boronate ester may also
assist in the characterization of loading, release, responsive-
ness and/or competitiveness with other diol species and even
for additional imaging purposes (15).
Previously, we reported the preparation and properties of
multilayered systems prepared from boronic acid-containing
poly(amido amine)s (BA-PAA) and chondroitin sulfate (ChS)
(21). Multilayer build-up of these films proceeds through elec-
trostatic interactions, mainly through the positively-charged
BA-PAA polymer chains and the negatively-charged sulfate-
containing ChS. Though possible, boronate ester formation is
not observed at a functional level for biomedical applications,
i.e. the binding between the BA-moieties in the BA-PAA poly-
mer and the diol groups in ChS is so weak that the BA-
moieties are largely present in their boronic acid state. Here
we describe our study into the use of BA-moieties in multilay-
ered BA-PAA films for reversible drug binding and triggered
release, using ARS as the model drug molecule.
MATERIALS AND METHODS
Chondroitin 4-sulfate sodium salt from bovine trachea (ChS,
≤10% water), alizarin red S (ARS), glucose (≥99.5%), gluta-
thione (≥98.0%), sulfuric acid (H2SO4, 95–98%), and hydro-
gen peroxide (H2O2, 30 wt% in H2O) were purchased from
Sigma-Aldrich (Zwijndrecht, The Netherlands). Sodium
dihydrogen phosphate monohydrate (NaH2PO4.H2O, 99.0–
102.0%), disodium hydrogen phosphate dihydrate
(Na2HPO4.2H2O, 99.5%), citric acid (≥99%), and trisodium
citrate dihydrate (≥99%) were purchased fromMerck (Darm-
stadt, Germany). Solvents were of reagent grade and used
without further purification unless otherwise noted. Milli-Q
water (18.2 MΩ∙cm at 25°C) was obtained from a Synergy®
water purification system (Millipore).
DAB-BA-PAA and ABOL-BA-PAA were synthesized as
described previously (21).
PBS buffer was prepared by dissolving 1.54 g of
Na2HPO4.2H2O, 0.3 g of NaH2PO4.H2O, and 8.2 g of NaCl
into 1.0 L of Milli-Q water and adjusting the pH to 7.4.
Citrate buffered saline (CBS buffer) pH 4, 5, and 6 were
prepared by dissolving citric acid, trisodium citrate dehydrate
and NaCl in the appropriate amounts in Milli-Q and
adjusting the pH with HCl or NaOH.
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UV characterization of multilayers was performed in the
dry state using a UV-2401 PC (Shimadzu, ‘s-Hertogenbosch,
The Netherlands) UV spectrophotometer. Each film fabricat-
ed on UV-transparent 7.5×37×1 mm quartz glass (Ted Pel-
la, Redding, USA) was measured in three different arbitrary
positions. Absorbance scan was carried out in the 200–700 nm
wavelength range. All data points were then corrected for
baseline offset by subtracting the absorbance value at
400 nm from each data point. Relative absorbance values
were obtained by normalizing each data point with the respec-
tive value at time 0.
Poly-D-lysine-coated 96 well plates (PDL-TCPS) for mul-
tilayer build-up for cell culture and transfection experiments
were purchased from Greiner (Alphen aan den Rijn,
The Netherlands).
COS-7 cells (European Collection of Animal Cell Cultures
(ECACC) Catalogue No. 87021302) were grown in DMEM
containing 4.5 g/L glucose and GlutaMAXTM (Invitrogen,
Breda, The Netherlands) supplemented with 2% (v/v)
PennStrepp (Lonza, Breda, The Netherlands) and 10% (v/v)
fetal bovine serum (Lonza, Breda, The Netherlands).
Fluorescence microscopy was performed at 4X, 10X, 20X,
and/or 40X objectives using EVOS digital inverted micro-
scope (EMS, Wageningen, The Netherlands).
Confocal microscopy was performed on an LSM 510 (Carl
Zeiss, Sliedrecht, The Netherlands) using the Zen 2009
software.
Fluorescence-activated cell sorting (FACS) was carried out
i n a Be c t on -D i c k i n s on FACSCa l i bu r ( B r e d a ,
The Netherlands).
Multilayered Thin Film Construction and Build-Up
Profiles
Fresh BA-PAA solutions were prepared shortly before the
start of multilayer build-up from the solid materials, which
had been re-lyophilized overnight to avoid weighing errors
due to their hygroscopic properties. All BA-PAA solutions
(2.0 mg/mL) were prepared in PBS buffer at pH 7.4 to avoid
possible variations in pH.
Prior to the assembly, quartz substrates (7.5×32 mm) were
etched for 30 min in piranha acid to activate the surface,
rinsed with copious amounts of Milli-Q water, and dried un-
der N2 stream. These substrates were then dipped into DAB-
BA-PAA or ABOL-BA-PAA solution (2 mg/mL in PBS buffer
pH 7.4) for 5 min, transferred into washing solution contain-
ing PBS buffer for 1 min, dipped briefly in a large amount of
Milli-Q water, transferred into ChS+ARS (2 mg/mL ChS
and 1 mM ARS in Milli-Q water) solution for 5 min, dipped
into the second washing solution containing Milli-Q water for
1 min, and finally followed by another brief dipping in Milli-
Q. This cycle was repeated to reach the desired number of
bilayer. Drying under N2 stream was performed after every
BA-PAA layer deposition, excluding the very first layer. The
resulting ensemble is denoted by BA-PAA-(ChS+ARS#BA-
PAA)n, where BA-PAA represents either DAB-BA-PAA or
ABOL-BA-PAA and n represents the number of bilayer.
The first BA-PAA layer is regarded as a precursor layer and
therefore excluded from the bilayer number count. Typically,
the ensemble consists of 5 or 10 bilayers with the poly(amido
amine) polymer as the last layer. For every multilayered sys-
tem, three samples were fabricated in parallel to give estima-
tion for standard deviation. To study the build-up profiles,
UV spectra were recorded after each drying step following
BA-PAA layer formation throughout the 200–700 nm range.
Every absorbance values were then corrected for baseline shift
at 700 nm. Afterwards, the multilayers were dipped into
ChS+ARS solution to continue multilayer build-up.
Multilayers for cell culture were fabricated directly in the
wells of poly-D-lysine-coated 96-well plates (PDL-TCPS,
Greiner) by alternatingly dispensing deposition (70 μL) and
washing (2x 100 μL) solutions under sterile conditions inside
the laminar flow hood (LFH). Deposition started with ChS+
ARS (2 mg/mL ChS and 1 mM ARS in Milli-Q water,
30 min for the first layer, 5 min next) as the first layer to a
total of 10 bilayers ending with the BA-PAA layer. No inter-
mediate drying steps were applied. At the end of the fabrica-
tion process, the plates were left inside the LFH briefly to dry
the films. Coated plates were kept at 4°C and used as soon as
possible (typically overnight). These multilayered samples are
designated as PDL-(ChS+ARS#BA-PAA)10 to indicate the
presence of a PDL layer as a precursor layer. Compared to
multilayers built on quartz and silicon wafer substrates, these
systems substitute the first BA-PAA layer with PDL layer in-
herent to the well plate surface.
ARS Release Under Physiological Conditions
and At Acidic pH
ARS release profiles of the three multilayered systems in PBS
buffer pH 7.4 at 37°C were investigated by dipping the thin
films formed on quartz slides in 2 mL of PBS buffer pH 7.4
solution and incubating them in a water bath with tempera-
ture set to 37°C. At regular intervals, the samples were re-
moved, briefly dipped in a large amount of Milli-Q water,
dried under N2 stream and measured by UV–vis spectropho-
tometer. The release study at acidic pH (pH 4, 5, and 6) was
carried out in a similar fashion, but using citrate buffered
saline (CBS) instead of PBS.
ARS Release Under Various Reductive Conditions
Degradability of themultilayered systems was investigated in a
similar way as for the investigation of their respective stability
profiles under physiological conditions, but in the presence of
0.4 mM or 10 mM glutathione in the incubation medium.
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Solutions containing glutathione in PBS buffer at pH 7.4 were
prepared fresh directly prior to the start of experiment. Due to
instability of glutathione in PBS buffer at pH 7.4, no solution
of more than three hours old was used.
ARS Release in the Presence of Glucose
The influence of glucose concentration on ARS release profile
was investigated in a similar way as for the investigation of
their respective stability profiles under physiological condi-
tions, but in the presence of 25 mM and 100 mM of glucose.
The 25 mM concentration is used to mimic the glucose con-
centration in cell culture medium. This concentration is
roughly 2.5 times the minimal blood glucose level in diabetic
patients (22).
Particle Uptake by COS-7 Cells: FACS
To investigate the possibility of COS-7 cells taking up ARS-
boronate ester from the multilayer surface, cells were seeded
directly on multilayer-coated wells at 20 000 cells/well or 62
500 cells/cm2 in complete medium with serum and left to
proliferate at 37°C under humidified atmosphere with 5%
CO2.
After 0, 3, 6, 12, 24, and 48 h, cells were trypsinized, cen-
trifuged (5min, 600 g), and analyzed by FACS. Cells were also
cultured for 12 h on regular polystyrene (PS) culture plates
with and without the addition of free ARS and on multilay-
ered films without ARS as controls to determine live cell pop-
ulation and fluorescence-positive cell population markers. On
some multilayered samples treated similarly but without addi-
tion of cells, physical force was applied to break down the films
into the cell culture medium. The resulting suspension was
also analyzed through FACS to locate multilayer remnant
population and identify their relative fluorescence intensity.
Excitation of ARS-boronate ester was performed at
488 nm and emission was detected via a 585 nm band-pass
filter. At least 20 000 – 30 000 total events were measured to
reach 10 000 events for gated living cells. Data analysis was
performed using the FACS Cellquest Software. The gate set-
ting was equal for all samples within the same experiment. Dot
plots were applied to separate living cells population from
dead cells and film residues and particles. From the histogram
obtained, markers were drawn to identify cells as live positive
cells or live negative cells.
Particle Uptake by COS-7 Cells: Confocal Microscopy
Samples for confocal microscopy were prepared by culturing
cells as described in previously. Following 24 h of culture, cells
were trypsinized and recultured inside a cover glass slide im-
aging chamber (General Electric Healthcare, Eindhoven,
The Netherlands) for 6 h to allow the cells to attach. The cells
were then washed with PBS, fixed with 3.7% paraformalde-
hyde for 15 min at RT, washed 3 times with PBS, and stained
with Hoechst 33258 (2 μL/mL in PBS) for 15 min at RT.
Samples were then washed 3 times with PBS and mounted
on a clean microscope glass slide using aqueous mount-
ing medium (Ibidi, Munich, Germany) and sealed with
nail polish.
Confocal microscopy was performed on an LSM 510 (Carl
Zeiss, Sliedrecht, The Netherlands) using Zen 2009 software.
Both fluorophores (BA-ARS andHoechst 33258) were excited
using a 543 nm argon laser passed through HFTKP 700/S43
and split through an NFT 490. BA-ARS fluorescence was
analyzed past a BP 565–615 IR filter and Hoechst 33258
excitation was analyzed past a BP 390–465 IR filter. Z-stack
sectioning was performed over 20 slices throughout the
33.75 μm height range.
RESULTS AND DISCUSSION
Multilayered Thin Film Build-Up
Wepreviously reported the syntheses of two branched boronic
acid-functionalized poly(amido amine)s (BA-PAAs) (21). The
degrees of BA functionalization of the two BA-PAAs were
similar at ~50%, with branching estimated to be ~10 and
~30% for DAB-BA-PAA and ABOL-BA-PAA, respectively,
and number average molecular weights of 12 and 14 kg/mol,
respectively. Chemical structures of the two polymers, ChS,
and ARS utilized in this study are presented in Scheme 1.
These polymers were employed in multilayer build-up as de-
scribed in the Materials and Methods section.
Figure 1 shows build-up profiles of DAB-BA-PAA-(ChS+
ARS#DAB-BA-PAA)10 and ABOL-BA-PAA-(ChS+
ARS#ABOL-BA-PAA)10 based on increases in absorbance
at 470 nm. Incorporation of the dark red ARS drastically
changes the spectral properties of the films, which complicates
relating the UV spectra of these films with previous ARS-free
multilayers (21). As the ARS is the reporter molecule for the
investigation of both loading and release, and no multilayer
build-up was observed in the absence of ChS, it was deemed
appropriate to study the film behavior based on the UV-
absorption of ARS. The opaque nature of the films is very
reminiscent to the ARS-free system, indicating that ChS still
makes up the majority of the material in the multilayered
system, providing thick films.
Figure 1 indicates relatively linear build-up profiles for the
two BA-PAAs. Both systems display a slow build-up in the
early stages of deposition, probably due to incomplete sub-
strate surface coverage, causing repulsion between the sub-
strate and the negatively-charged ARS molecules. The subse-
quent linear increase of ARS absorbance values indicates that
ARS is incorporated systematically as the bilayer number
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increases. Incorporation of ARS proved to bemore efficient in
the ABOL-BA-PAA multilayers than in the DAB-BA-PAA
multilayers. This is in contrast to the previous study showing
that DAB-BA-PAA facilitated deposition of ChS and resulted
in overall thicker films, as compared to ABOL-BA-PAA (21).
However, this study was based on the absorbance specific to
ChS (at 258 nm) and therefore did not provide information on
the amount of incorporated BA-PAA polymer. The higher
ARS uptake in the ABOL-BA-PAA#ChS multilayers may
indicate that ABOL-BA-PAA multilayers contain a higher
ABOL-BA-PAA/ChS ratio than DAB-BA-PAA/ChS ratio
of DAB-BA-PAA#ChS multilayers, thereby making it possi-
ble to incorporate more ARS into the films through BA-ARS
interactions. At 5 and 10 bl, ABOL-BA-PAA-based films con-
tain 2 and 1.3 times more ARS, respectively, as compared to
DAB-BA-PAA-based films at the same bl number. The inset
in the UV spectra of Fig. 1 shows the digital photograph of
DAB-BA-PAA-(ChS+ARS#DAB-BA-PAA)10 and ABOL-
BA-PAA-(ChS+ARS#ABOL-BA-PAA)10. The image re-
veals that DAB-BA-PAA-(ChS+ARS#DAB-BA-PAA)10 con-
tains less ARS than ABOL-BA-PAA-(ChS+ARS#ABOL-
BA-PAA)10.
With DAB-BA-PAA possessing higher positive charge den-
sity due to the protonated amines in the side chains, it may be
expected that additional electrostatic interactions with the
negatively charged ARS may help to incorporate additional
ARS in the DAB-BA-PAA#ChS multilayer films. However,
our previous attempts to incorporate various other charged
small dye molecules through loading into multilayers purely
by electrostatic interactions were unsuccessful. Often the dyes
acted as salts, enhancing deposition of polyelectrolytes without
being incorporated (unpublished results). It is therefore ex-
pected that ARS-boronate ester formation is the major driv-
ing force for the successful incorporation of ARS into the (BA-
PAA#ChS) multilayers.
As a pH indicator, ARS with a pKa of ~4.5 is known to
change color from yellow to red in the pH range of 3.5 – 6.5
(23). Throughout the multilayer build-up, ChS+ARS depo-
sition solution in water was red in color (pH ~7), while the pH
of the BA-PAA deposition solutions was maintained at 7.4
through the use of phosphate buffer. If the color of ARS in
the constructs was determined solely by the pH of the deposi-
tion solutions, a redmultilayered film with λmax above 500 nm
would be formed. However, the color of the films (Fig. 1, inset)
was orange rather than red, with a λmax at 470 nm. This λmax
of the multilayers at 470 nm was maintained throughout the
10 cycles of deposition investigated. It is known from the lit-
erature that the ARS-phenylboronate ester (BA-ARS) pos-
sesses a relatively high association constant (1300 M−1 at
pH 7.4, 0.10M phosphate buffer) (12). In contrast, ChS which
contains vicinal diol groups with larger dihedral angles only
forms labile boronate esters with BA, which are further weak-
ened by electrostatic repulsion of the boronate anion by the
sulfate and carboxylic acid groups of ChS. Therefore, the
orange color is most likely attributed to boronate ester forma-
tion of ARS with phenylboronic acid (BA) moieties in the BA-
PAA (18). This finding of multilayer λmax at 470 nm is in
agreement with previous findings by Ding et al. (24).
Scheme 1 Chemical structures of DAB-BA-PAA, ABOL-BA-PAA, ChS, and ARS.
Fig. 1 (a) UV-Absorption-based
build-up profiles (470 nm) and (b)
UV spectra of DAB-BA-PAA-
(ChS+ARS#DAB-BA-PAA)n and
ABOL-BA-PAA-(ChS+
ARS#ABOL-BA-PAA)n in the dry
film. Inset in (a) shows the build-up
profiles of multilayers in the absence
of ARS; inset in (b) shows digital
photograph of DAB-BA-PAA-
(ChS+ARS#DAB-BA-PAA)10 (left)
and ABOL-BA-PAA-(ChS+
ARS#ABOL-BA-PAA)10 (right).
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As further compari son, DAB-BA-PAA-(PVA+
ARS#DAB-BA-PAA)10 – an ARS-loaded multilayer pre-
pared with PVA instead of ChS – remained red instead of
orange (data not shown), indicating significant competition
between diols of PVA and ARS for ester formation with BA.
Due to the multivalency and high local concentration of vici-
nal diol groups in PVA, the majority of BA moieties is bound
to PVA, leaving the ARS molecules only physically entrapped
or loosely bound in this multilayer.
It is important to note that the BA-PAA#ChS multilayer
films have an opaque appearance, which especially manifests
at higher number of layers. This hampers accurate UV deter-
minations. Therefore, in order to minimize possible errors in
UV characterization, the number of bilayers in the subsequent
studies on pH-, glucose-responsiveness, and degradation of
the layers has been limited to 5 bilayers.
ARS Release Profiles Under Physiological Conditions
and At Acidic pH
Due to the pH-sensitive nature of the boronate ester forma-
tion (12), ARS is expected to be rapidly released at acidic pH
where boronate ester formation is less favorable. To investi-
gate the ARS release profiles from the multilayered systems
under physiological conditions and at acidic pH, the films
were incubated in PBS at pH 7.4, and in CBS at pH 6, 5,
or 4 at 37°C. The ARS release profiles are depicted in Fig. 2
indicating that within 12 h of incubation under physiological
conditions (pH 7.4), about 30% and 40% of the incorporated
ARS was released for DAB-BA-PAA and ABOL-BA-PAA
systems, respectively. ARS release continued, though substan-
tially slower, reaching a plateau after 10 days of incubation
where ~50% of the incorporated ARS was released from the
multilayered constructs. The rapid release of ARS under
physiological conditions may be facilitated by entropic gain
from the liberation of ARS molecules before finally reaching
an equilibrium at ~50% ARS content.
ABOL-BA-PAAmultilayers, possessing a higher loading of
ARS than the DAB-BA-PAAmultilayers, releasedmore of the
ARS content during the initial rapid release phase. This
means that under equal conditions and at the same number
of bilayers, much more ARS is released to the incubation
medium by the ABOL-BA-PAA system, than in the case of
the DAB-BA-PAA system. Also, since the release was only
followed by the decrease in ARS absorbance in the multi-
layers, it is not deducible from these results whether or not
also BA-PAA polymers or ChS were released during the initial
release phase. Our previous results with ARS-free multilayers
showed that up to ~20% of the polymeric components of the
multilayers were also released within 2 h of incubation under
the same conditions (21). Therefore, the release observed in
Fig. 2 may represent the release of a mixture of both free ARS
and ARS-boronate ester complexes.
At acidic pH, ARS-boronate ester is less stable (12) and
leads to more rapid ARS release. At pH 6, at least two times
faster release of ARS is observed, as compared to the release at
pH 7.4. At more acidic pH the release proceeds progressively
faster, and complete ARS release was achieved at pH 5 and 4,
after 17 h and 5 h, respectively. In relation to the potential
application where these multilayers are used to coat the sur-
face of implantable biomaterials or devices, low-pH-triggered
release may be exploited to deliver diol- or catechol-
containing anti-inflammatory drugs (25,26). Since implanta-
tion surgery is followed by inflammatory response, decreasing
pH locally, these multilayered coatings may help in reducing
inflammation by delivering the correct dosage based on the
change in pH of the environment.
As discussed previously, ARS is a pH indicator. The equi-
libria between the different ARS species are depicted in
Scheme 2, including those in the presence of BA moieties. In
the presence of these moieties, the high binding constant be-
tween ARS and BA drives the equilibrium towards boronate
ester formation with a distinctly different λmax. This boronate
ester is only stable at neutral to basic pH, where it is predom-
inantly present in the negatively charged tetrahedral form
(12). Therefore, upon decrease of pH, the equilibria are
shifted towards free ARS, which are then shifted further to
the yellow species (λmax=419 nm) by the low pH. Figure 3
shows the expected decrease in λmax during the incubation in
the different acidic pH values. As shown in Scheme 2, this shift
in λmax is accompanied by ARS-boronate ester hydrolysis,
leading to ARS release from the films.
During the first hour of exposure to PBS buffer at pH 7.4,
the λmax of the multilayers remains stable at 470 nm, followed
by a shift to longer wavelength throughout the rest of the
incubation period. The shift in λmax reached a maximum
value at ~510 nm after about 20 days of incubation. Unlike
in the case of acidic pH, this shift in λmax progressed much
more slowly, underlining the high binding affinity of the BA to
ARS at pH 7.4. The initial 1 h rapid release of ARS (Fig. 2) is
not accompanied by a shift in λmax. This further indicates most
of the incorporated ARS is bound to BA moieties or involved
in dynamic ester formation (27) with the BA moieties in the
film. In the later stages of incubation, slow gradual boronate
ester hydrolysis and diffusion of ARS take place, leaving
higher portions of unbound physically-entrapped ARS in the
multilayer, resulting in a shift of λmax to that corresponding to
free ARS at pH 7.4 (λmax=519 nm).
ARS Release Under Reducing Conditions
Owing to the presence of disulfide bonds in the main polymer
chain of the BA-PAAs, the resulting multilayered ensembles
are responsive to the presence of reducing agents as well. This
reducibility is demonstrated by exposing the multilayers to
0.4 mM and 10mM of glutathione in the incubation solutions
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of PBS at pH 7.4. Figure 4 shows the ARS release profiles
under these reducing conditions. In the presence of 0.4 mM
glutathione, ARS release is not significantly enhanced as com-
pared to that observed in the absence of glutathione, at least
during the first 10 h of incubation. This slow response to
0.4 mM glutathione was also observed for the degradation
of the ARS-free multilayers, and can be attributed to their
relatively high structural stability due to the branched struc-
ture of the polymers. However, during prolonged incubation,
disulfide reduction progressed more extensively (incubation
duration>10 h), ARS release displayed an increased release
compared to the release observed in the absence of glutathi-
one. At the higher glutathione concentration of 10 mM the
accelerated release was more pronounced and complete ARS
release and film degradation was achieved after 10 h of
incubation.
ARS Release In The Presence of Glucose
As a diol-containing molecule, glucose may compete with
ARS in binding to the BA-moieties in the (BA-PAA#ChS)
multilayers, which can result in a glucose-triggered ARS re-
lease from the multilayers. However, the results in Fig. 5 show
that ARS release is only slightly increased by the presence of
glucose at elevated concentration of 100 mM, and even de-
creased at 25 mM glucose concentration. At 25 mM glucose
concentration, the slightly slower initial ARS release, as com-
pared to the release in the absence of glucose, is probably due
Fig. 2 ARS release profiles under
physiological conditions and acidic
pH in vitro. Left part of the abscissa
shows release within 1 day; right
part shows slower release during
remaining incubation.
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to increases in osmotic pressure in the incubation medium,
leading to an overall effect of decreased ARS diffusion
from the films. In general, the absence of any significant
glucose-response is likely due to the much stronger
binding constant of BA with ARS than with glucose
(i.e. ~300-fold stronger (12)). Furthermore, pronounced
ARS release may have been further hampered by slow
diffusion of glucose into and ARS out of the ChS-rich
multilayered construct.
Figure 5 further shows that albeit minor, ABOL-BA-PAA
(white symbols) displayed slightly more increased responsive-
ness to glucose than DAB-BA-PAA (black symbols). At the
same glucose concentration of either 25 or 100 mM, more
pronounced ARS release was observed for ABOL-BA-PAA
multilayers than for DAB-BA-PAA systems. This may be at-
tributed to the weaker interaction between the neutral prima-
ry alcohol side groups of ABOL-BA-PAA with the negatively-
charged ChS, as compared to the more positively-charged
primary amines of DAB-BA-PAA. In the former case, weaker
interaction may lead to pronounced swelling that enhances
ARS release, while in the latter case, presence of additional
positive charges may restrict release due to electrostatic inter-
action between ARS and the protonated amines.
The change in λmax throughout the incubation in glucose
solution (Fig. 6) shows a distinct trend. The λmax of DAB-BA-
PAA multilayers displays a more rapid red-shift (pointing to
free ARS) than ABOL-BA-PAA, with no significant depen-
dence on glucose concentration. A similar trend was observed
for films incubated under physiological conditions. DAB-BA-
PAAmultilayers eventually have higher λmax than ABOL-BA-
PAAmultilayers, which could indicate that the ARS-boronate
ester in DAB-BA-PAA multilayers is weaker than in the
ABOL-BA-PAA system. The pronounced red-shift of λmax is
probably enhanced by the lower diffusion coefficient of
negatively-charged ARS from the multilayers, which contains
higher amounts of positively-charged primary amine side
groups. Thus, it is likely that in a typical DAB-BA-PAA mul-
tilayer, ARS ismore readily freed from the boronate ester with
BA, but remains physically entrapped within the multilayers,
hence resulting in a change in λmax.
The increased stability of ABOL-BA-PAA with ARS as
compared to DAB-BA-PAA, may be the primary alcohol side
Fig. 4 Degradation profiles of
DAB-BA-PAA-(ChS+ARS#DAB-
BA-PAA)5 and ABOL-BA-PAA-
(ChS+ARS#ABOL-BA-PAA)5 in
PBS at pH 7.4 containing 0.4 or
10 mM glutathione at 37°C in vitro.
Fig. 3 Maximum wavelength shift
of ARS molecules within DAB-BA-
PAA-(ChS+ARS#DAB-BA-PAA)5
and ABOL-BA-PAA-(ChS+
ARS#ABOL-BA-PAA)5 films at
various pH.
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groups of ABOL-BA-PAA in the proximity of BA, which may
provide additional stabilization of the ARS-boronate ester. It
is known that boronate esters are more stable in their tetrag-
onal anion form (12); in a compact layer of BA-PAA, primary
alcohols in the vicinity may donate their free electron pairs,
effectively lowering the apparent pKa of the BA (Scheme 3).
In contrast, as the majority of primary amines in DAB-BA-
PAA is protonated, less electron pair donation can be provid-
ed by these groups.
Uptake of ARS by COS-7 Cells Cultured on Multilayers
In this study, multilayered thin films of (ChS+ARS#BA-PAA)
are investigated as a drug delivery system with ARS as a re-
porter molecule. As observed through the previous release
study, these multilayers may serve as a drug reservoir to pro-
vide sustained release under physiological conditions or trig-
gered release by changes in pH or through reducing
conditions.
The ARS-boronate ester within the multilayered surface is
fluorescent and may serve as a fluorescent label for the
detection of cellular uptake of ARS-boronate esters. These
ARS-boronate esters may be released from the multilayers
either in the form of nanoparticles in which ARS is embedded
and covalently bound to BA as boronate ester, or as more
labile BA-PAA aggregates with weaker ARS binding. Earlier
it has been found that ABOL-BA-PAA polymers can self-
assemble into nano-sized particles (15). Dynamic light scatter-
ing studies on 0.6 mg/mL solutions of ABOL-BA-PAA in
50 mM HEPES buffer at pH 7.4 revealed the presence of
homogeneous particles of ~94 nm, with a positive zeta poten-
tial (up to +40 mV). The same solution of DAB-BA-PAA
showed higher polydispersity and lower zeta potential
(+4 mV) (data not shown). These observations may be
an indication that multilayers of ABOL-BA-PAA may
provide a larger amount of ARS-complexed nanoparti-
cles than the DAB-BA-PAA multilayers. Such an effect
could be relevant for cellular uptake of ARS by cells
cultured on top of the multilayers, since nanoparticles
with positive zeta potential are more readily internalized
by cells and contain more stable and longer lasting BA-
ARS complexes.
Fig. 5 ARS release profiles under
physiological conditions and in the
presence of 25 and 100 mM
glucose in vitro.
Fig. 6 Maximum wavelength shift
of ARS molecules within DAB-BA-
PAA-(ChS+ARS#DAB-BA-PAA)5
and ABOL-BA-PAA-(ChS+
ARS#ABOL-BA-PAA)5 films in the
presence of 25 and 100 mM
glucose.
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To investigate whether ARS can be delivered by the films
to become internalized by cells cultured on the multilayered
surfaces, COS-7 cells were cultured on 96-well poly-D-lysine-
coated tissue culture-treated polystyrene (PDL-TCPS), coated
with (ChS+ARS#BA-PAA)10. The degree of cellular uptake
of polymer-bound ARS was determined at 0, 3, 6, 12, 24, and
48 h time points after seeding of the cells on the multilayers.
After the designated culture duration, cells were trypsinized,
fixed and stored at 4°C before being measured at the end of
the experiment. Trypsinization was found to not cause disso-
lution of themultilayered surface (data not shown). In addition
to the cells cultured on the (ChS+ARS#BA-DAB)10 (entry
#1) and (ChS+ARS#BA-ABOL)10 (entry #2) multilayers,
several controls were prepared for a more thorough analysis
as elaborated in Table I. Multilayered systems without cells
(entries #5–8) served as a guideline to separate live cell popu-
lations from the population of film debris and/or particles in
the FACS analysis. Cells seeded on PS well plates without
multilayers (entry #9) served as negative control to help gate
for live cells. Cells seeded on multilayers without ARS,
(ChS#DAB-BA-PAA)10 (entry #3), and (ChS#ABOL-BA-
PAA)10 (entry #4), and on PS with additional ARS in the
medium (entry #10) served as a guideline to establish amarker
to separate positive cells (i.e. cells that have taken up fluores-
cent ARS-boronate ester) from negative cells, and to verify
that detected fluorescence is only from the ARS-boronate
ester. The degree of cellular uptake is presented in two ways;
i.e. 1) as percentage of positive cells in the live cell population,
and 2) as relative fluorescence intensity of sample suspensions.
Typical dot plots for the different conditions are shown in
Fig. 7a. From the different plots, three regions can be distin-
guished representing populations of live cells (R1), particles or
multilayer remnants and small particles (R2) or dead cells
(R3). Region R2 is determined based on the single population
obtained from no-cell controls (entries #5–8), where shear
forces have been applied to disintegrate the multilayered sur-
face. Dot plot similarity between ARS samples (entry #1–2)
and PS (entry #9) and PS+ARS (entry #10) controls indicate
that no multilayer components were included in the sample
suspensions.
Histograms were plotted to correlate number of events
gated on live cells (G1–R1) with the respective fluorescence
intensity (Fig. 7b). A distinct difference can be observed be-
tween cells cultured on PS and PS+ARS where a right shift in
cell population is observed for PS+ARS as compared to PS.
The shift indicates a slight increase in fluorescence intensity,
which is induced by the presence of free unbound ARS. Tak-
ing this phenomenon into account, the latter systems were
deemed as a more suitable negative control to set the
M1 marker to isolate positive (BA-ARS fluorescent) cells
from negative populations. Finally, the same marker is
applied for the statistical analysis to determine the
Scheme 3 Acid–base equilibria between trigonal boronic acid and vicinity primary alcohol side group of ABOL-BA-PAA and the subsequent boronate ester
formation with ARS.
Table I List of Samples and Controls Incorporated During Cellular Uptake Studies and Their Respective Abbreviations
Entry Sample name Category Abbreviation
1 (ChS+ARS#DAB-BA-PAA)10 with cells ARS DAB-BA-PAA
2 (ChS+ARS#ABOL-BA-PAA)10 with cells ABOL-BA-PAA
3 (ChS#DAB-BA-PAA)10 with cells No ARS DAB-BA-PAA no-ARS
4 (ChS#ABOL-BA-PAA)10 with cells ABOL-BA-PAA no-ARS
Controls without cells
5 (ChS+ARS#DAB-BA-PAA)10 without cells No cells DAB-BA-PAA no-cell
6 (ChS+ARS#ABOL-BA-PAA)10 without cells ABOL-BA-PAA no-cell
7 (ChS#DAB-BA-PAA)10 without cells No ARS, no cells DAB-BA-PAA no-ARS-no-cell
8 (ChS#ABOL-BA-PAA)10 without cells ABOL-BA-PAA no-ARS-no-cell
Controls without multilayer
9 PS with cells PS PS
10 PS with cells seeded in medium containing ARS PS+ARS PS+ARS
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degree of cellular uptake within positive samples gated
for live cells (G1).
Figure 8a shows the degree of cellular uptake against dif-
ferent durations of incubation. PS (entry #9), PS+ARS (entry
#10), and no-ARS (entry #3–4) control data were collected
after 12 h incubation and showed no significant degree of
uptake, despite the long culture duration (Fig. 8a, first three
bars). The 0 h incubation data was obtained by collecting the
FACS sample directly after cell seeding on multilayered sur-
faces. As the duration of incubation was simply too short for
intracellular uptake, any positive signals of positive cells would
indicate physical association of burst-released multilayer com-
ponents on the cell surface. Figure 8a shows that at 0 h, no
significant uptake or physical association was detected. Upon
longer culture durations, the degree of uptake increased and
reached optimal values at 20 and 30% of BA-ARS positive
cells for DAB-BA-PAA and ABOL-BA-PAA, respectively,
before decreasing to a stable value of 10% after 48 h culture
time. Longer culture duration was not attempted as the cells
would have grown past confluency, while passage of the con-
fluent cell monolayer to the same surface did not result in
substantial degrees of uptake after another 48 h of culture
(data not shown). This observation may indicate that the ini-
tial burst release observed in Fig. 2 is critical in delivering
particles to be taken up by the cells. Following the initial 6 h
(for DAB-BA-PAA system) and 12 h (for ABOL-BA-PAA sys-
tem) incubation, cells proliferated and thus decreased the
overall degree of cellular uptake.
Another way to follow the extent of BA-ARS uptake by the
cells is by determination of the overall fluorescence intensity in
the sample suspension, i.e. not only the cells within the M1
marker, but the whole sample suspension, including the posi-
tive values from free ARS without BA (see Fig. 7b). Figure 8b
shows that at the respective optimal culture duration, the
a
b
R1
R2
R3
Fig. 7 (a) Representative dot plots
of: (from left to right, top to bottom)
multilayer fragments (see text), PS,
PS+ARS, DAB-BA-PAA, and
ABOL-BA-PAA after 12 h of culture
duration. Three regions are select-
ed on every dot plot, namely R1 for
live cells (largest region to the right),
R3 for dead cells (bottom left
corner), and R2 (left part of dot plot)
most apparent for multilayer frag-
ment populations shown in the first
dot plot. (b) Overlay histogram of
samples gated for live cells (G1=
R1).
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detected fluorescence intensity was approximately two times
higher than that of the 0 h value. Further, as opposed to
Fig. 8a where the degree of uptake decreased at least twofold
after the optimal culture duration, Fig. 8b shows relatively
stable fluorescence intensity indicating that the absolute
amount of positive live cells were likely maintained through-
out the 48 h culture duration. Fluorescence intensity detected
at 0 h was most likely due to burst-released free ARS from the
films as supported by a similar fluorescence intensity detected
in the 12 h incubated PS+ARS controls (entry #9, Fig. 7b).
When the fluorescence intensity of each sample is corrected
for the fluorescence intensity of the PS+ARS controls, the
resulting fluorescence intensity can be regarded to emerge
from ARS-boronate ester formation (see Scheme 2). In that
respect, when no-cell controls were subjected to shear forces
(entry #5 and 6) in order to measure the relative fluorescence
intensity of the multilayer alone, the fluorescence intensity
detected was approximately 10-fold the optimal values shown
in Fig. 8b. According to the detected fluorescence intensities,
the ABOL-BA-PAA system facilitates deposition of ARS and
correspondingly more ester formation with the BA-function-
ality, as compared to the DAB-BA-PAA system.
Noticeable differences between the two BA-PAAs are ob-
served in Fig. 8a where the ABOL-BA-PAA systemmay sustain
cellular uptake of proliferating cells for as long as 12 h, while the
DAB-BA-PAA reached the optimal value already after 6 h cul-
ture duration. This may be attributed to three factors, i.e. the
higher initial incorporation of ARS, enhanced ARS-boronate
ester formation, and/ormore efficient release of ARS-boronate
ester in the former system. As observed in Fig. 2, ABOL-BA-
PAA incorporates and releases more ARS during the initial
12 h release phase.Moreover, as shown in Fig. 6 and Scheme 3,
ABOL-BA-PAA potentially may also form stronger ARS-
boronate esters through the presence of primary alcohols in
the vicinity. Next, it was indicated previously that ABOL-BA-
PAA polymer self-assembles into monodispersed nano-sized
Fig. 8 (a) Degree of cellular
uptake of multilayer components
and (b) mean fluorescence
intensity/cell against cell culture
duration.
Fig. 9 (a) Overlaid fluorescence (20X magnification, bar=200 μm) and (b) confocal (40X magnification) microscopy images of COS-7 cells after 20 h culture
duration on a (ChS+ARS#ABOL-BA-PAA)10 multilayer sample and reseeded onto clean imaging chambers. Insets show higher magnification of selected clusters
of cells (white squares) and those specifically imaged through confocal microscopy (yellow square). (c) Overlaid fluorescence image of mechanically disrupted
(ChS+ARS#ABOL-BA-PAA)10 sample without cells at 4X magnification (bar=1000 μm).
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particles that may be internalized more efficiently by cells (15),
whereas DAB-BA-PAA provides more disperse particles of low-
er positive surface charges. As such, albeit showing relatively
similar behavior to DAB-BA-PAA throughout the in vitro re-
lease studies, the ABOL-BA-PAA may eventually provide re-
lease of more nanoparticles that are better internalized by cells
and contain more stable ARS-boronate ester.
To assess whether the fluorescent ARS-boronate esters de-
tected by FACS are indeed internalized by cells and not mere-
ly physically attached onto the outer membrane of the cells,
cells which have been cultured for 20 h were trypsinized,
reseeded on imaging chambers, and left to attach for 6 h be-
fore staining and fixating for confocal microscopy imaging.
Complementing the confocal microscopy, regular fluores-
cence microscopy was employed to obtain a lower magnifica-
tion, more global view of the samples. No significant differ-
ences were observed between the DAB-BA-PAA and ABOL-
BA-PAA systems and therefore images of the latter are shown
here as representative results (Fig. 9).
Figure 9b indicates that most of the observed fluorescent
particles are indeed taken up by the cells and are not merely
adhering to the outer cell membranes. Moreover, these parti-
cles co-localize with the Hoechst-stained nuclei. Larger fluo-
rescent aggregates are observed as well, which were physically
associated with the cells and/or located at the peri-nuclear
region (indicated by arrow). As a control, PDL-(ChS+
ARS#ABOL-BA-PAA)10 was mechanically destroyed and
observed under the fluorescence microscope (Fig. 9c), reveal-
ing multilayer fragments. These remnants fluoresced brightly
under the same conditions indicating that the observed fluo-
rescent particles indeed orifinate from the multilayered sur-
face onto which cells were cultured. No such fluorescence was
observed for cells cultured on PS surfaces (data not shown).
CONCLUSIONS
Multilayered thin films from boronic acid-functionalized
poly(amido amine)s (BA-PAA) and chondroitin sulfate (ChS)
have been evaluated for their abilities in facilitating cellular
uptake of the dye alizarin red S (ARS) as a reporter molecule.
The dynamic covalent bonding between ARS and BAmoieties
in the polymers facilitates systematic loading during the multi-
layer build-up and provides facile characterization through the
fluorescence properties of the boronate ester. UV spectroscopy
shows linear build-up profiles with distinct λmax indicating suc-
cessful incorporation of ARS. It is postulated that during build-
up, the majority of incorporated ARS was present in dynamic
equilibrium with BA moieties of the BA-PAAs, resulting in a
stable maximum wavelength of absorption (λmax) at 470 nm,
corresponding to the λmax of ARS-boronate ester.
The ARS-boronate ester retains pH responsiveness, and
more rapid release is obtained upon lowering pH from neutral
(pH 7.4) to pH 6, 5, and 4. Concomitant shifts in λmax were
observed, in agreement with ARS-boronate ester hydrolysis
and ARS’ properties as a pH indicator. Under physiological
conditions (pH 7.4), it was proposed that initial burst release of
up to 40% (12 h) represents the release of excess ARS, which
was initially in dynamic equilibrium within the multilayered
films. After 1 h incubation, the λmax shifted very slowly,
reaching a plateau at ~510 nm after 20 days of total incuba-
tion, indicating the relatively strong ARS-boronate ester for-
mation at pH 7.4. Parallel to the slow increases in λmax, ARS
was released very slowly, indicating low diffusion coefficients
of ARS out of the multilayered structure.
Due to the possibility of competitive boronate ester forma-
tion with other diol-containing molecules such as glucose,
ARS release was also investigated in the presence of relatively
high glucose concentrations. No significant response was ob-
served at glucose concentrations of 25 and 100 mM due to the
much higher binding constant of BA to ARS than to glucose.
The observation of the λmax change during the glucose incu-
bation experiment indicated that DAB-BA-PAA gave a faster
response than ABOL-BA-PAA, i.e. the λmax red-shifted faster.
It was hypothesized that primary alcohol side groups in the
vicinity of BA reaction center in ABOL-BA-PAA may help by
acting as Lewis bases, consequently lowering the pKa of the
BA moiety and form stronger boronate esters with ARS. The
faster response of DAB-BA-PAA to glucose, however, did not
result in enhanced ARS release, which was explained by the
slow diffusion of ARS out of the multilayered and rigid film,
leaving free unbound ARS trapped inside the film acting as
pH indicator (i.e. demonstrating higher λmax at pH 7.4).
For the study of cellular uptake, flow cytometry indicated
that compared to the controls, the release of ARS-boronate
ester is characterized by significantly higher fluorescence inten-
sity. Cellular uptake was found to be maximal at 20 and 30%
following 6 h of culture for DAB-BA-PAA and ABOL-BA-
PAA films, respectively. For the latter system, the degree of
cellular uptake was maintained for at least another 6 h, most
likely through the higher amount and stronger ARS-boronate
ester formed with ABOL-BA-PAA. Confocal microscopy
further revealed presence of fluorescent particles that
were internalized by cells and often co-localized with
the cell nuclei, indicating successful delivery of ARS in
its boronate ester form with BA-PAAs into the nuclei of
the cells cultured on top of the films. Our current re-
search efforts are aimed at exploiting these multilayered
thin films as drug delivery systems.
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